The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Miller, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Miller, R. G.

The Journal of Immunology, Vol 155, Issue 7 3464-3471, Copyright © 1995 by American Association of Immunologists


ARTICLES

Down-regulation of CD8 on mature antigen-reactive T cells as a mechanism of peripheral tolerance

L Zhang, W Fung-Leung and RG Miller
Ontario Cancer Institute, University of Toronto, Ontario, Canada.

Previously we have shown that intravenous injection of male B6 lymphocytes containing CD8+ cells into B6 female anti-HY TCR transgenic mice results at 6 wk in the disappearance of the majority of male Ag- reactive T cells (TghighCD8+) from the periphery. Here we investigate the process in more detail. B6 female anti-HY TCR transgenic mice were intravenously injected with viable lymphocytes from male B6 normal, CD4- /-, CD8-/- or CD8-/- carrying a CD8 transgene lacking its cytoplasmic tail ("CD8 tail-less") mice. The fate of TghighCD8+ cells was followed in vivo. There was always a large (at least twofold) expansion of these cells in the periphery 4 days after encountering male Ag. Their subsequent fate differed, however, depending on whether or not the injected male lymphocytes contained normal CD8-expressing cells. If the injected male lymphocytes contained normal CD8 cells, at 6 wk there was a large drop in the number of TghighCD8+ cells associated with a rise in the number of TghighCD8- cells. If the injected male lymphocytes lacked CD8 cells or expressed only tail-less CD8, TghighCD8+ cell numbers returned to normal by 6 wk, while TghighCD8- cell numbers remained unchanged. The TghighCD8- cells, although carrying high levels of the male specific TCR, did not react to male Ag. In addition, their ability to respond in anti-CD3-induced activation, which does not require CD8 as a co-receptor, was significantly impaired. Our data suggest that down-regulation of CD8 on the Ag-reactive T cells accounts, at least partially, for the disappearance of HY-reactive T cells from the periphery. Further, some step in the process requires signaling through the cytoplasmic domain of CD8 on the injected Ag- bearing cells.


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
Z. Xiao, M. F. Mescher, and S. C. Jameson
Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation
J. Exp. Med., October 29, 2007; 204(11): 2667 - 2677.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Z. Illes, H. Waldner, J. Reddy, A. C. Anderson, R. A. Sobel, and V. K. Kuchroo
Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background
Int. Immunol., October 1, 2007; 19(10): 1235 - 1248.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Ford, Z.-X. Zhang, W. Chen, and L. Zhang
Double-Negative T Regulatory Cells Can Develop Outside the Thymus and Do Not Mature from CD8+ T Cell Precursors.
J. Immunol., September 1, 2006; 177(5): 2803 - 2809.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Illes, H. Waldner, J. Reddy, E. Bettelli, L. B. Nicholson, and V. K. Kuchroo
T Cell Tolerance Induced by Cross-Reactive TCR Ligands Can Be Broken by Superagonist Resulting in Anti-Inflammatory T Cell Cytokine Production
J. Immunol., August 1, 2005; 175(3): 1491 - 1497.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Maile, C. A. Siler, S. E. Kerry, K. E. Midkiff, E. J. Collins, and J. A. Frelinger
Peripheral "CD8 Tuning" Dynamically Modulates the Size and Responsiveness of an Antigen-Specific T Cell Pool In Vivo
J. Immunol., January 15, 2005; 174(2): 619 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Maile, B. Wang, W. Schooler, A. Meyer, E. J. Collins, and J. A. Frelinger
Antigen-Specific Modulation of an Immune Response by In Vivo Administration of Soluble MHC Class I Tetramers
J. Immunol., October 1, 2001; 167(7): 3708 - 3714.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Adler, C.-T. Huang, G. S. Yochum, D. W. Marsh, and D. M. Pardoll
In Vivo CD4+ T Cell Tolerance Induction Versus Priming Is Independent of the Rate and Number of Cell Divisions
J. Immunol., January 15, 2000; 164(2): 649 - 655.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. J. Adler, D. W. Marsh, G. S. Yochum, J. L. Guzzo, A. Nigam, W. G. Nelson, and D. M. Pardoll
CD4+ T Cell Tolerance to Parenchymal Self-Antigens Requires Presentation by Bone Marrow-derived Antigen-presenting Cells
J. Exp. Med., May 18, 1998; 187(10): 1555 - 1564.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Stohlman, C. C. Bergmann, M. T. Lin, D. J. Cua, and D. R. Hinton
CTL Effector Function Within the Central Nervous System Requires CD4+ T Cells
J. Immunol., March 15, 1998; 160(6): 2896 - 2904.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Yang, B. D. Temple, Q. Khan, and L. Zhang
Mechanisms of Long-Term Donor-Specific Allograft Survival Induced by Pretransplant Infusion of Lymphocytes
Blood, January 1, 1998; 91(1): 324 - 330.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.